CIBC Private Wealth Group
CHRS icon

CIBC Private Wealth Group’s Coherus Oncology CHRS Stock Holding History

CIBC Private Wealth Group’s Portfolio CHRS Stock Details CHRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$175 Hold
123
– – ﹤0.01% 3245
2025
Q3 		$202 Hold
123
– – ﹤0.01% 2950
2025
Q2 		$90 Hold
123
– – ﹤0.01% 2973
2025
Q1 		$95 Hold
123
– – ﹤0.01% 2994
2024
Q4 		$186 Hold
123
– – ﹤0.01% 2895
2024
Q3 		$128 Hold
123
– – ﹤0.01% 3045
2024
Q2 		$156 Hold
123
– – ﹤0.01% 3071
2024
Q1 		$295 Buy
+123
New +$303 ﹤0.01% 2969

Other funds holding CHRS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.66B AUM 11.67% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

CIBC Private Wealth Group's CHRS Position: Q4 2025 in Review

CIBC Private Wealth Group held its Coherus Oncology (CHRS) position steady in Q4 2025 at 123 shares worth $175. The position accounts for ﹤0.01% of the portfolio, ranked #3245.

CIBC Private Wealth Group first reported a position in CHRS in Q1 2024 and has held it in 8 quarters since. The position peaked at $295 in Q1 2024. 127 funds tracked by Wall St. Rank hold CHRS as of Q4 2025.

  • CIBC Private Wealth Group held 123 shares of Coherus Oncology worth $175 as of Q4 2025.
  • CIBC Private Wealth Group left its Coherus Oncology share count unchanged in Q4 2025.
  • Coherus Oncology made up ﹤0.01% of CIBC Private Wealth Group's portfolio in Q4 2025, its #3245 holding.
  • CIBC Private Wealth Group first reported a position in Coherus Oncology in Q1 2024 and has held it in 8 quarters since.
  • CIBC Private Wealth Group's Coherus Oncology position peaked at $295 in Q1 2024.
  • 127 funds tracked by Wall St. Rank held Coherus Oncology as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.